FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
What Patients Need to Know About Lung Cancer Immunotherapy August 14, 2015December 14, 2022 Michelle Liew
New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer July 7, 2015December 14, 2022 Matthew Tontonoz